Opinion
Video
Author(s):
Panelists discuss how patients and caregivers at the late-line treatment stage commonly struggle with profound concerns about diminishing treatment options, increased uncertainty about prognosis, managing complex and often cumulative side effects, financial toxicity from years of therapy, caregiver burnout, practical challenges of more frequent hospitalizations, anxiety about becoming refractory to novel agents, navigating clinical trial eligibility, maintaining hope while being realistic and balancing aggressive treatment approaches with quality of life considerations as therapeutic choices narrow.
Video content above is prompted by the following: